120 related articles for article (PubMed ID: 7508232)
21. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.
Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP
J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213
[TBL] [Abstract][Full Text] [Related]
22. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection.
Lambkin HA; Mothersill CM; Kelehan P
J Pathol; 1994 Jan; 172(1):13-8. PubMed ID: 7931822
[TBL] [Abstract][Full Text] [Related]
23. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs.
Teifke JP; Löhr CV
J Comp Pathol; 1996 Feb; 114(2):205-10. PubMed ID: 8920221
[TBL] [Abstract][Full Text] [Related]
25. Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck.
Lavieille JP; Lubin R; Soussi T; Reyt E; Brambilla C; Riva C
Anticancer Res; 1996; 16(4C):2385-8. PubMed ID: 8816839
[TBL] [Abstract][Full Text] [Related]
26. Detection of p53 and histopathological classification of skin tumours induced by halogen lamps in hairless mice.
D'Agostini F; Fiallo P; Di Marco C; De Flora S
Cancer Lett; 1994 Nov; 86(2):167-75. PubMed ID: 7982204
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas.
Mørkve O; Laerum OD
Cytometry; 1991; 12(5):438-44. PubMed ID: 1935458
[TBL] [Abstract][Full Text] [Related]
28. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
29. Inter-observer variation of p53 immunohistochemistry--an assessment of a practical problem and comparison with other studies.
Kay EW; Barry Walsh CJ; Whelan D; O'Grady A; Leader MB
Br J Biomed Sci; 1996 Jun; 53(2):101-7. PubMed ID: 8757686
[TBL] [Abstract][Full Text] [Related]
30. p53 DO-1 immunohistochemical overexpression in premalignant and malignant cervical lesions.
Skopelitou A; Kamina S; Krikoni O; Alexopoulou V; Agnantis NJ
Anticancer Res; 1997; 17(1A):269-75. PubMed ID: 9066664
[TBL] [Abstract][Full Text] [Related]
31. p53 gene mutations in human epithelial skin cancers.
Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
[TBL] [Abstract][Full Text] [Related]
32. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
34. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
35. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.
Porter PL; Gown AM; Kramp SG; Coltrera MD
Am J Pathol; 1992 Jan; 140(1):145-53. PubMed ID: 1731521
[TBL] [Abstract][Full Text] [Related]
36. High frequency of p53 expression in colo-rectal adenomatous polyps.
Boccuzzi A; Terzolo M; Leonardo E; Cappia S; Tappero G; Paccotti P; Angeli A
Anticancer Res; 1995; 15(4):1407-10. PubMed ID: 7654029
[TBL] [Abstract][Full Text] [Related]
37. Expression of insulin-like growth factor-I receptor in primary cutaneous carcinomas.
Keehn CA; Saeed S; Bickle K; Khalil FK; Morgan MB
J Cutan Pathol; 2004 May; 31(5):368-72. PubMed ID: 15059221
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer.
McGregor JM; Yu CC; Dublin EA; Levison DA; MacDonald DM
Br J Dermatol; 1992 Nov; 127(5):463-9. PubMed ID: 1467284
[TBL] [Abstract][Full Text] [Related]
39. Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
Terada T; Shimizu K; Izumi R; Nakanuma Y
Mod Pathol; 1994 Feb; 7(2):249-52. PubMed ID: 8008749
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Lukás J; Rejthar A; Kovarík J; Midgley CA; Gannon JV; Lane DP
Oncogene; 1991 Sep; 6(9):1699-703. PubMed ID: 1923535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
